Lpl Financial LLC Taysha Gene Therapies, Inc. Transaction History

Lpl Financial LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$2.04 - $4.17 $12,235 - $25,011	5,998 Added 14.26%	48,060 $107,000
Q1 2024 May 10, 2024	SELL	$1.43 - $3.25 $22,877 - $51,993	-15,998 Reduced 27.55%	42,062 $120,000
Q4 2023 Feb 14, 2024	BUY	$1.33 - $2.88 $1,496 - $3,240	1,125 Added 1.98%	58,060 $102,000
Q3 2023 Nov 13, 2023	BUY	$0.63 - $3.66 $35,869 - $208,382	56,935 New	56,935 $179,000

119

136M

25.9K

24K

Ticker TSHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,359,500
Market Cap $119M
Description
Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for th...

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Lpl Financial LLC with notifications on news.